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Introduction: Surgical treatment of velopharyngeal insufficiency (VPI) in 22q11.2 deletion
syndrome is often warranted. In this patient population, VPI is characterized by poor palatal
elevation and muscular hypotonia with an intact palate. We hypothesize that 22q11.2 dele-
tion patients are at greater risk of obstructive sleep apnea (OSA) after surgical correction
of VPI, due, in part, to their functional hypotonia, large velopharyngeal gap size, and the
need to surgically obstruct the velopharynx.
Methods: We performed a retrospective analysis of patients with 22q11.2 deletion syn-
drome treated at a tertiary pediatric hospital between the years of 2002 and 2012. The
incidence of VPI, need for surgery, post-operative polysomnogram, post-operative VPI
assessment, and OSA treatments were evaluated.
Results: Forty-three patients (18 males, 25 females, ages 1–14 years) fitting the inclu-
sion criteria were identified. Twenty-eight patients were evaluated by speech pathology
due to hypernasality. Twenty-one patients had insufficient velopharyngeal function and
required surgery. Fifteen underwent pharyngeal flap surgery, three underwent sphincter
pharyngoplasty, two underwent Furlow palatoplasty, and one underwent combined sphinc-
ter pharyngoplasty with Furlow palatoplasty. Of these, eight had post-operative snoring.
Six of these underwent polysomnography (five underwent pharyngeal flap surgeries and
one underwent sphincter pharyngoplasty). Four patients were found to have OSA based
on the results of the polysomnography (average apnea/hypopnea index of 4.9 events/h,
median=5.1, SD=2.1). Two required continuous positive airway pressure (CPAP) due to
moderate OSA.
Conclusion: Surgery is often necessary to correct VPI in patients with 22q11.2 deletion
syndrome. Monitoring for OSA should be considered after surgical correction of VPI due
to a high occurrence in this population. Furthermore, families should be counseled of the
risk of OSA after surgery and the potential need for treatment with CPAP.
Keywords: obstructive sleep apnea, velopharyngeal insufficiency, velopharyngeal dysfunction, 22q11.2 deletion
syndrome, velocardiofacial syndrome, DiGeorge syndrome, pharyngeal flap, Furlow palatoplasty
INTRODUCTION
The 22q11.2 deletion syndrome is the most frequent human
microdeletion syndrome (1). It has a frequency of 1:6000–1:2000
(2, 3). Significant phenotypic heterogeneity is found among
affected individuals. Anatomic and functional concerns include
characteristic facies, congenital heart disease, immune disorders,
hypocalcemia, hearing loss, cleft palate, hypotonia, feeding diffi-
culties, developmental delay, psychiatric issues, speech delay, and
velopharyngeal insufficiency (VPI) (4–6).
The incidence of VPI in patients with 22q11.2 deletion syn-
drome ranges from 27% of patients to 80% (7, 8). Poor func-
tioning of the velopharyngeal mechanism may be due to var-
ious anatomic and functional reasons. Overt cleft palate and
submucous cleft palate are infrequently identified in patients
with this syndrome and are known to be associated with VPI
(Figure 1) (9). Generalized muscular hypotonia, also, often affects
the muscles of the palate, contributing to a poor velopharyngeal
mechanism.
The VPI associated with 22q11.2 deletion syndrome is known
to be more difficult to treat, and studies have demonstrated infe-
rior surgical outcomes when patients with this syndrome are
compared to non-syndromic patients (10, 11). However, surgi-
cal treatment of VPI in these patients is often warranted to correct
their resonance disorder. Surgical options to correct VPI include
posterior pharyngeal augmentation, palatoplasty (double oppos-
ing z-plasty and intravelar muscular repositioning), sphincter
pharyngoplasty, pharyngeal flap pharyngoplasty, and combina-
tions of these procedures. Each of these procedures narrow the
velopharyngeal port and thus predispose patients to obstructive
sleep apnea (OSA) (12).
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FIGURE 1 | Image of a persistent velopharyngeal gap causing
velopharyngeal insufficiency in a patient with a submucous cleft
palate undergoing video nasopharyngeal endoscopy (PPW=posterior
pharyngeal wall,VPG=velopharyngeal gap, SP= soft palate).
In recent years, OSA occurrence has been increasingly acknowl-
edged as a frequent and significant complication after the cor-
rection of VPI. Studies have demonstrated a significant risk of
OSA within non-syndromic patients undergoing velopharyngeal
surgery for VPI (13–15). The incidence of OSA in the 22q11.2 dele-
tion syndrome population is not well described. Decreased upper
airway tone with pharyngeal and palatal muscular hypotonia can
contribute to OSA (16). Additionally, the high rate of congenital
cardiac malformations in this population may create a physiol-
ogy, which is not tolerant for the potential hypoxia associated with
OSA (17).
The risk of OSA in the 22q11.2 deletion syndrome population
after surgery for VPI is also poorly described. The aim of this
study is to evaluate patients with 22q11.2 deletion syndrome and
VPI necessitating surgical intervention in order to determine the
risk of OSA. We hypothesize that these patients are at greater risk
of OSA post-operatively, due, in part, to their functional hypotonia
and the need to surgically obstruct the velopharynx.
MATERIALS AND METHODS
Approval for the study was obtained by an institutional review
board at Vanderbilt University. A retrospective review of patients
with 22q11.2 deletion syndrome treated at the tertiary pediatric
hospital associated with Vanderbilt University was performed
between the years of 2002 and 2012. Inclusion criteria included all
patients with 22q11.2 deletion syndrome under the age of 18 years
at treatment as identified through an electronic medical record
search. Genetic evaluation in conjunction with the results of the
fluorescent in situ hybridization test was identified in order to
confirm the diagnosis of 22q11.2 deletion syndrome in all patients
included in the study.
The surgical treatments were also assessed to ensure that
they were performed between the years included in the review.
Patients were only referred for surgical treatment after aggressive
FIGURE 2 | Image of a persistent large velopharyngeal gap causing
velopharyngeal insufficiency in a patient with 22q11.2 deletion
syndrome undergoing video nasopharyngeal endoscopy
(PPW=posterior pharyngeal wall,VPG=velopharyngeal gap, SP= soft
palate).
speech therapy. All patients were evaluated by two speech-language
pathologists and a surgeon experienced in the treatment of VPI
prior to any recommendation for surgery. All patients undergo
video nasopharyngeal endoscopy to evaluate the velopharyn-
geal function, closure pattern, and velopharyngeal gap prior to
surgery (Figure 2). The operative procedures performed for each
patient were decided based on the expertise of the treating sur-
geon using the results of the video nasopharyngeal endoscopy as
a guide. Patients with large velopharyngeal gaps and those with
an adynamic velopharyngeal mechanism underwent a pharyngeal
flap procedure. Those with lateral gaps or “bowtie” closure pat-
terns underwent a sphincter pharyngoplasty. Furlow palatoplasty
(18) was reserved for patients with small gaps with a dynamic
velopharyngeal mechanism and for those with a submucous cleft
palate. The combination of Furlow palatoplasty and sphincter
pharyngoplasty was recommended in patients with a moderate
velopharyngeal gap.
The incidence of VPI, need for surgery, post-operative
polysomnogram (PSG), post-operative VPI assessment, and
OSA treatments were specifically evaluated. The primary out-
come measure was incidence and severity of OSA, as con-
firmed by polysomnography, after velopharyngeal surgery. Sleep
apnea was diagnosed when the apnea/hypopnea index (AHI) on
polysomnography was >1 event/h (19). An increased AHI was con-
sidered to be consistent with an increase in the severity of the sleep
apnea. Severity of sleep apnea was categorized as mild (AHI >1
event/h to 5 events/h), moderate (AHI between 5 and 10 events/h),
or severe (AHI >10 events/h).
RESULTS
Forty-three patients (18 males, 25 females, ages 1–14 years) fit-
ting the inclusion criteria were identified. Twenty-eight of the 43
patients were evaluated by the speech-language pathology team
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due to concern for hypernasality. Seven of these 28 patients
had sufficient velopharyngeal closure for normal speech and
were treated with speech therapy. Twenty-one of the 28 patients
evaluated by the speech-language pathology team had insuffi-
cient velopharyngeal function and were subsequently referred for
surgery. Fifteen of the 21 patients underwent pharyngeal flap
surgery, 3 of the 21 underwent sphincter pharyngoplasty, 2 of the
21 underwent Furlow palatoplasty, and 1 of the 21 underwent
combined sphincter pharyngoplasty with Furlow palatoplasty
(Table 1).
Of the 21 patients who required velopharyngeal surgery, 5 had
a submucous cleft palate and 1 had a cleft of the secondary palate.
The remainder did not have an identifiable anatomic difference. All
patients demonstrated improvement in their post-operative per-
ceptual speech evaluation by the speech-language pathology team.
However, two patients had persistent VPI to the extent that further
surgery was recommended. One of these underwent a revision of
their pharyngeal flap and the other a revision of their sphincter
pharyngoplasty. Adequate improvement was noted by the speech-
language pathology team after the revision was performed in the
patient with the pharyngeal flap. However, a second revision was
necessary for the patient with the sphincter pharyngoplasty. After
the second revision, the patient had sufficient velopharyngeal clo-
sure for speech,as assessed by the speech-language pathology team.
Post-operatively, eight patients began snoring. Six of these
eventually underwent polysomnography due to the severity of
the snoring and a clinical suspicion for OSA (five had pharyn-
geal flap surgeries and one underwent a sphincter pharyngoplasty,
ages 3–6 years). The sleep studies were performed at an average of
2.6 years after the surgery for VPI (median= 1.7, SD= 2.3, range
of 6 months–6 years). The average AHI of all those undergoing
post-operative polysomnography was 3.6 events/h (median= 3.3,
SD= 2.6). The results of the polysomnography demonstrated
OSA in four patients (average AHI of 4.9 events/h, median= 5.1,
SD= 2.1). Two patients were placed on continuous positive airway
pressure (CPAP) due to moderate OSA with an average AHI of 6.6
events/h. Both of these patients had already undergone further sur-
gical treatment for sleep disordered breathing prior to their PSG.
One patient underwent a tonsillectomy and the other underwent
a midline posterior glossectomy with a lingual tonsillectomy (as
an adenotonsillectomy had already been performed earlier in life
due to concern for sleep disordered breathing). The results of the
remaining two patients demonstrated mild OSA with an average
AHI of 3.3 events/h and both were treated conservatively (moni-
toring and/or a nasal steroid spray with montelukast). Table 2 lists
the treatments and results of all the patients who underwent PSGs.
Of note, one of the patients on CPAP therapy began to have
improved sleep symptoms after 3 years and a repeat PSG was
performed. The study demonstrated an AHI of 1.8 events/h and
he was able to discontinue CPAP therapy. Only one patient with
OSA confirmed by polysomnography underwent a PSG prior to
velopharyngeal surgery. The initial study was performed 1 year
prior to surgery on the velopharynx, but after an adenotonsillec-
tomy for symptoms consistent with sleep disordered breathing.
The study demonstrated an AHI of 0.2 events/h. This patient
subsequently underwent a repeat PSG 1 year after surgery, which
demonstrated mild OSA (AHI of 2.4 events/h).
Table 1 | Patient characteristics of those included in the study with the
corresponding values.
Patient Characteristics Value
Total patients with 22q11.2 deletion syndrome 43
Female (% of total) 25 (58)
Male (% of total) 18 (42)
Patients with VPI requiring surgery (% of total) 21 (49)
Pharyngeal flap (% of pts requiring surgery) 15 (71)
Sphincter pharyngoplasty (% of pts requiring surgery) 3 (14)
Furlow palatoplasty (% of pts requiring surgery) 2 (10)
Combination Furlow and Sphincter (% of pts requiring surgery) 1 (5)
Patients diagnosed with OSA based on PSG (% of pts requiring
surgery)
4 (19)
Patients requiring CPAP (% of pts requiring surgery) 2 (10)
DISCUSSION
This study demonstrates that OSA is a possible postoperative com-
plication in patients with 22q11.2 deletion syndrome who undergo
surgery for VPI. OSA was confirmed with polysomnography in 4
of the 21 patients (19%) who required surgery. Fortunately, those
identified with OSA were all in the mild to moderate range (AHI
<10 events/h). Only two patients were placed on CPAP due to con-
cern for the severity of their OSA. One of these patients was able to
discontinue CPAP after 3 years due to improvement in their PSG.
The remaining patients in the study did not undergo polysomnog-
raphy and thus we cannot confirm or deny OSA in this population.
This group of patients either did not snore and/or the clinical sus-
picion for OSA was not present. Of note, only one patient with
confirmed OSA underwent a sleep study prior to proceeding with
surgery on their velopharyngeal port, making the data difficult to
interpret.
Recent studies have started to take into account the concern
for OSA when performing velopharyngeal surgery, especially on
syndromic populations. Rottgers et al. (17) proposed an algo-
rithm for the application of the Furlow palatoplasty in treating
VPI in patients with 22q11.2 deletion syndrome. Essentially, the
authors propose that all patients with an overt cleft or a submu-
cous cleft palate with a kinetic palate should undergo a Furlow
palatoplasty (pharyngeal flaps were performed for revisions and
akinetic palates). One of the primary reasons for this proposal,
according to the authors, is that Furlow palatoplasty can be effec-
tive in select populations and is less likely to cause post-operative
OSA. Using this method, the authors did not have any patients
present with symptoms of OSA, although polysomnography data
are not included. They found this algorithm to be successful in
the treatment of VPI in many patients with 22q11.2 deletion syn-
drome, although the potential for secondary pharyngoplasty must
be considered.
Similarly, recent studies have also demonstrated the effective-
ness of performing a pharyngeal flap or sphincter pharyngoplasty
in patients with 22q11.2 deletion syndrome and VPI (20–22).
Spruijt et al. (21) performed a systematic review in search of
the optimal surgical treatment for velopharyngeal dysfunction
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Table 2 | Demographics of the patients who underwent polysomnography, including the surgery performed for their VPI, pre and
post-polysomnography treatments of OSA, and AHI results of the PSG.
Age (in years) Sex VPI Surgery Pre-PSG OSA surgery Post-OP AHI OSA treatment
3 F Pharyngeal flap Adenoidectomy 1.0 events/h Conservative
4 F Sphincter pharyngoplasty None 4.1 events/h Conservative
4 M Pharyngeal flap T&A, MPG, LT 6.1 events/h CPAP
5 M Pharyngeal flap Tonsillectomy 7.0 events/h CPAP
6 M Pharyngeal flap None 1.0 events/h Conservative
6 F Pharyngeal flap T&A 2.4 events/h Conservative
PSG= polysomnography, AHI= apnea/hypopnea index, OSA=obstructive sleep apnea, T&A= tonsillectomy and adenoidectomy, MPG=midline posterior glossec-
tomy, LT= lingual tonsillectomy.
in 22q11.2 deletion syndrome. Based on their review, they con-
cluded that a grade C recommendation could be made to perform
a pharyngoplasty directly in order to minimize the morbidity of
further revision surgery that is more likely to occur when a palato-
plasty alone is performed. Interestingly, in that review, only 1%
of the 525 patients with 22q11.2 deletion syndrome were noted to
have OSA after surgery for VPI. In all of these studies, the diagnosis
and incidence of OSA is often minimized and based solely on clin-
ical symptomatology and not polysomnography. Several studies
of pediatric OSA have confirmed that clinical symptoms are poor
predictors of OSA demonstrated on polysomnography (23–25).
Though our study is a retrospective review, it does demon-
strate that within this syndromic population, a risk of OSA exists
following operative repair of VPI, and the rate of OSA is higher
than previously reported. Clinicians should have a low threshold
to perform polysomnography on patients with 22q11.2 deletion
syndrome following VPI operations. While the ideal interval is
unknown, waiting 6 months postoperatively may allow for res-
olution of temporary postoperative edema. Assessment of post-
operative OSA is especially important in the 22q11.2 deletion
syndrome population as there is a high rate of comorbidities,
such as cognitive delays and cardiac anomalies, which would be
negatively impacted by fragmented sleep, catecholamine dysregu-
lation, and hypoxia/hypercarbia. Further studies are necessary in
order to quantify the risk of postoperative (and preoperative) OSA,
determine its severity, and identify variables to improve outcomes.
CONCLUSION
Surgery is often used to treat VPI in patients with 22q11.2 dele-
tion syndrome. OSA after surgery for VPI in this population is
a known complication. Based on this retrospective review, moni-
toring for OSA should be considered before and after surgery due
to its known occurrence and the severity of morbidity that may
be associated with it, especially in these syndromic patients. Fur-
thermore, families should be counseled of this risk after surgery
and the potential need for CPAP treatment. Additional prospec-
tive studies with pre- and post-surgical polysomnography data are
needed to further explore the complication of OSA after surgery
on the velopharynx.
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